Abstract:Peroxisome proliferator‐activated receptor alpha (PPAR‐α) is a major transcription factor that governs the expression of fatty acid oxidation (FAO) and anti‐inflammatory genes during fasting. Acyl‐CoA thioesterase 1 (ACOT1) hydrolyzes acyl‐CoAs to long‐chain free fatty acids and Coenzyme A during fasting. ACOT1 activity seemingly removes acyl‐CoA substrate for mitochondrial FAO and produces long‐chain free fatty acids that could serve as ligands to activate PPAR‐α. The objective of this research was to identify the role of ACOT1 in hepatic fasting lipid metabolism. To test our objectives, we injected C57Bl/6 mice with an adenovirus harboring shRNA targeted to ACOT1 or a scrambled control. Week‐long liver specific knockdown of ACOT1 increased FAO in vivo measured by serum β‐hydroxybutyrate and reduced liver triglyceride. These data correlated to results from in vitro fatty acid tracer studies in which ACOT1 knockdown increased FAO and triglyceride turnover. Despite increased FAO, ACOT1 knockdown reduced the expression of PPAR‐α target genes involved in FAO. In addition, ACOT1 knockdown led to increased expression of inflammatory and oxidative stress genes, due to reduced PPAR‐α dependent anti‐inflammatory signaling. Moreover, in vitro experiments exhibited increased PPAR‐α reporter activity in COS7 cells overexpressing ACOT1. The ability of ACOT1 to increase PPAR‐α activity was dependent on its catalytic activity, suggesting that ACOT1 produces fatty acids that serve as ligands for PPAR‐α. To confirm this theory, mice were supplemented with a synthetic PPAR‐α ligand, Wy‐14643, which rescued the expression of PPAR‐α target genes and mitigated the inflammation and oxidative stress observed in response to ACOT1 knockdown. Importantly, ACOT1 exhibits nuclear localization during prolonged fasting or under β‐adrenergic stimulation, suggesting a local pool of free fatty acids activate PPAR‐α.Together these studies suggest that ACOT1 coordinates the rate of fatty acid oxidation while simultaneously producing fatty acids that activate PPAR‐α, potentially in the nucleus, to protect the liver from inflammation and oxidative stress. Support or Funding Information NIH/NIDDK T32 Training grant, Minnesota Obesity Training Program Predoctoral Fellowship (DK083250), awarded to Mallory Franklin.

Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition

Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet

Abstract 19596: Endothelial Acyl-CoA Synthetase 1 is not Required for Saturated Fatty Acid- Mediated Inflammatory and Apoptotic Effects

Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption

Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways

Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

Acyl‐CoA Thioesterase 1 regulates hepatic lipid metabolism and PPAR‐α signaling

Adipocyte Ablation of Long‐Chain Acyl‐CoA Synthetase‐4 (ACSL4) Protects Against Diet‐Induced Obesity

The Role of Acyl-CoA Synthetase 1 in Bioactive Lipid Accumulation and the Development of Hepatic Insulin Resistance

Deficiency in Hepatic ATP-citrate Lyase Affects VLDL-triglyceride Mobilization and Liver Fatty Acid Composition in Mice.

A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction

Tip60-mediated Lipin 1 Acetylation and ER Translocation Determine Triacylglycerol Synthesis Rate

Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice

Liver ACOX1 regulates levels of circulating lipids that promote metabolic health through adipose remodeling

Loss of carnitine palmitoyltransferase 1a reduces docosahexaenoic acid-containing phospholipids and drives sexually dimorphic liver disease in mice

ACSL1 affects Triglyceride Levels through the PPAR Pathway

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

Effects of Long-Chain Fatty Acyl-CoA Synthetase 1 on Diglyceride Synthesis and Arachidonic Acid Metabolism in Sheep Adipocytes

Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.

Loss of Long-Chain Acyl-Coa Synthetase 1 Promotes Hepatocyte Death in Alcohol-Induced Steatohepatitis

Metabolic and Tissue-Specific Regulation of Acyl-CoA Metabolism